Related Experiment Videos
Surgery and ablative therapy for hepatocellular carcinoma.
Charles Cha1, Ronald P DeMatteo, Leslie H Blumgart
1Hepatobiliary Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Journal of Clinical Gastroenterology
|November 27, 2002
Summary
Hepatocellular carcinoma (HCC) is a common cancer with increasing incidence. Early detection through advanced imaging allows for curative treatments like surgery or transplantation, improving patient survival and quality of life.
Area of Science:
- Hepatology
- Oncology
- Medical Imaging
Background:
- Hepatocellular carcinoma (HCC) is a globally prevalent malignancy with rising US incidence.
- Historically poor prognosis for HCC is improving due to earlier detection methods.
- HCC accounts for approximately one million deaths annually worldwide.
Purpose of the Study:
- To review the current therapeutic landscape for Hepatocellular Carcinoma (HCC).
- To emphasize the importance of early detection in improving HCC patient outcomes.
- To outline the rational application of diverse treatment modalities for HCC.
Main Methods:
- Review of current literature on HCC diagnosis and treatment.
- Analysis of therapeutic options including surgery, transplantation, and local ablative therapies.
- Discussion on the criteria for selecting appropriate HCC treatments.
Main Results:
- Early HCC detection via improved imaging and surveillance enables curative treatment options.
- Partial hepatectomy and liver transplantation offer potentially curative therapies for select HCC patients.
- Local ablative therapies provide palliation for unresectable HCC.
Conclusions:
- Timely diagnosis and tailored treatment strategies are crucial for maximizing survival and quality of life in HCC patients.
- Transplantation is reserved for HCC patients with significant underlying liver dysfunction.
- A multidisciplinary approach integrating various therapies optimizes HCC management.